The DOI matches its Crossref record; 220 of the 220 references it cites were found in a registry or an index.
Biased signalling: from simple switches to allosteric microprocessors
Open accessAbstract
G protein-coupled receptors (GPCRs) are the largest class of receptors in the human genome and some of the most common drug targets. It is now well established that GPCRs can signal through multiple transducers, including heterotrimeric G proteins, GPCR kinases and β-arrestins. While these signalling pathways can be activated or blocked by 'balanced' agonists or antagonists, they can also be selectively activated in a 'biased' response. Biased responses can be induced by biased ligands, biased receptors or system bias, any of which can result in preferential signalling through G proteins or β-arrestins. At many GPCRs, signalling events mediated by G proteins and β-arrestins have been shown to have distinct biochemical and physiological actions from one another, and an accurate evaluation of biased signalling from pharmacology through physiology is crucial for preclinical drug development. Recent structural studies have provided snapshots of GPCR–transducer complexes, which should aid in the structure-based design of novel biased therapies. Our understanding of GPCRs has evolved from that of two-state, on-and-off switches to that of multistate allosteric microprocessors, in which biased ligands transmit distinct structural information that is processed into distinct biological outputs. The development of biased ligands as therapeutics heralds an era of increased drug efficacy with reduced drug side effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–220 of 220
Lovell, K. M., Frankowski, K. J., Stahl, E. L., Slauson, S. R., Yoo, E., Prisinzano, T. E., Aubé, J., & Bohn, L. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00092 · Cited by 65
Chen, X., Bai, B., Tian, Y., Du, H., & Chen, J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.574020 · Cited by 64
Snyder, J. C., Rochelle, L. K., Lyerly, H. K., Caron, M. G., & Barak, L. S. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.447540 · Cited by 62
Persistent cAMP signaling by internalized TSH receptors occurs in thyroid but not in HEK293 cells
Werthmann, R. C., Volpe, S., Lohse, M. J., & Calebiro, D. (2012) · The FASEB Journal · doi:10.1096/fj.11-195248 · Cited by 59
β-Arrestin mediates the Frank–Starling mechanism of cardiac contractility
Abraham, D., Davis, R. T., Warren, C. M., Mao, L., Wolska, B. M., Solaro, R. J., & Rockman, H. A. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1609308113 · Cited by 58
Kendall, R. T., Lee, M., Pleasant, D. L., Robinson, K., Kuppuswamy, D., McDermott, P. J., & Luttrell, L. M. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.595728 · Cited by 54
A unique mechanism of -blocker action: Carvedilol stimulates -arrestin signaling
Wisler, J. W., DeWire, S. M., Whalen, E. J., Violin, J. D., Drake, M. T., Ahn, S., Shenoy, S. K., & Lefkowitz, R. J. (2007) · Cited by 52
Self-citationFay, J. F., & Farrens, D. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1500895112 · Cited by 50
Peddibhotla, S., Hedrick, M. P., Hershberger, P., Maloney, P., Li, Y., Milewski, M., Gosalia, P., Gray, W., Mehta, A., Sugarman, E. D., et al. (2013) · ACS Medicinal Chemistry Letters · doi:10.1021/ml400176n · Cited by 47
Kenakin, T. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13217 · Cited by 45
Onaran, H. O., Rajagopal, S., & Costa, T. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.09.010 · Cited by 44
Self-citationML314: A Biased Neurotensin Receptor Ligand for Methamphetamine Abuse
Barak, L. S., Bai, Y., Peterson, S. M., Evron, T., Urs, N. M., Peddibhotla, S., Hedrick, M. P., Hershberger, P., Maloney, P., Chung, T. D. Y., et al. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.6b00291 · Cited by 44
Wootten, D. L., Reynolds, C. A., Smith, K. J., Mobarec, J. C., Furness, S. G. B., Miller, L. J., Christopoulos, A., & Sexton, P. M. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.08.015 · Cited by 44
Structure-Activity Analysis of Biased Agonism at the Human Adenosine A3 Receptor
Baltos, J., Paoletta, S., Nguyen, A. T. N., Gregory, K. J., Tosh, D. K., Christopoulos, A., Jacobson, K. A., & May, L. T. (2016) · Molecular Pharmacology · doi:10.1124/mol.116.103283 · Cited by 43
Vecchio, E. A., Chuo, C. H., Baltos, J., Ford, L., Scammells, P. J., Wang, B. H., Christopoulos, A., White, P. J., & May, L. T. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.08.007 · Cited by 39
Hu, J., Stern, M. K., Gimenez, L. E., Wanka, L., Zhu, L., Rossi, M., Meister, J., Inoue, A., Beck‐Sickinger, A. G., Gurevich, V. V., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.702282 · Cited by 33
Corbisier, J., Huszagh, A., Galès, C., Parmentier, M., & Springael, J. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.757559 · Cited by 29
Chuo, C. H., Devine, S. M., Scammells, P. J., Krum, H., Christopoulos, A., May, L. T., White, P. J., & Wang, B. H. (2016) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12616 · Cited by 25
Psychotomimetic Effects of Kappa Opioid Receptor Agonists
White, K. L., & Roth, B. L. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.08.014 · Cited by 21
Wanka, L., Babilon, S., Burkert, K., Mörl, K., Gurevich, V. V., & Beck‐Sickinger, A. G. (2016) · Cellular Signalling · doi:10.1016/j.cellsig.2016.11.003 · Cited by 10
Cited by
Mechanisms of physiological and pathological cardiac hypertrophy
Nakamura, M., & Sadoshima, J. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0007-y · Cited by 1,658
Mechanisms of signalling and biased agonism in G protein-coupled receptors
Wootten, D., Christopoulos, A., Marti-Solano, M., Babu, M. M., & Sexton, P. M. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0049-3 · Cited by 724
Common activation mechanism of class A GPCRs
Zhou, Q., Yang, D., Wu, M., Guo, Y., Guo, W., Zhong, L., Cai, X., Dai, A., Jang, W., Shakhnovich, E. I., et al. (2019) · eLife · doi:10.7554/elife.50279 · Cited by 632
G protein-coupled receptors: structure- and function-based drug discovery
Yang, D., Zhou, Q., Labroska, V., Qin, S., Darbalaei, S., Wu, Y., Yuliantie, E., Xie, L., Tao, H., Cheng, J., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00435-w · Cited by 632
Sex differences in anxiety and depression: circuits and mechanisms
Bangasser, D. A., & Cuarenta, A. (2021) · Nature Reviews Neuroscience · doi:10.1038/s41583-021-00513-0 · Cited by 479
Metadata
- Authors
- Smith, J. S., Lefkowitz, R. J., & Rajagopal, S.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2018-01-05
- Volume
- 17
- Issue
- 4
- Pages
- 243-260
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2782408527
- Cited by
- 738
- References
- 220
- FWCI
- 6.79
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.